Isoflavones, substances with multi-biological and clinical properties

Mingqiang Ren, Gerda Kuhn, Jochen Wegner, Jie Chen

Research output: Contribution to journalReview article

107 Citations (Scopus)

Abstract

Isoflavones, rich in soybean, are currently receiving much attention because of their potential role in preventing and treating cancer and other human chronic diseases. The present review provides an overview of the recent results in this research field. Data from epidemiological reports and laboratories have shown that isoflavones have multi-biological and pharmacological effects in animals and humans. These include estrogenic and antiestrogenic effects, cell signalling conduction, as well as cell growth and death. Based on these properties, soy protein and isoflavones have been associated with reduced incidences of breast and prostate cancers, cardiovascular diseases or osteoporosis, and exhibit some other favorable effects. The mechanism through which isoflavones may exert the above-mentioned functions are not only based on the estrogenic properties of isoflavones, but also on their role as protein tyrosine kinase inhibitors, as regulators of gene transcription, modulators of transcription factors, antioxidants, as well as by altering some enzyme activities. However, to draw a clear conclusion regarding the clinical use of isoflavones further investigation would be required, although only a few effects of short- or longterm use of soy proteins are known in humans.

Original languageEnglish (US)
Pages (from-to)135-146
Number of pages12
JournalEuropean Journal of Nutrition
Volume40
Issue number4
DOIs
StatePublished - Jan 1 2001

Fingerprint

Isoflavones
Soybean Proteins
Regulator Genes
Protein Kinase Inhibitors
Soybeans
Protein-Tyrosine Kinases
Osteoporosis
Prostatic Neoplasms
Estrogens
Chronic Disease
Cell Death
Transcription Factors
Cardiovascular Diseases
Antioxidants
Pharmacology
Breast Neoplasms
Incidence
Enzymes
Growth
Research

Keywords

  • Cancer
  • Cholesterol
  • Estrogen receptor
  • Isoflavones
  • Soy protein

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Isoflavones, substances with multi-biological and clinical properties. / Ren, Mingqiang; Kuhn, Gerda; Wegner, Jochen; Chen, Jie.

In: European Journal of Nutrition, Vol. 40, No. 4, 01.01.2001, p. 135-146.

Research output: Contribution to journalReview article

Ren, Mingqiang ; Kuhn, Gerda ; Wegner, Jochen ; Chen, Jie. / Isoflavones, substances with multi-biological and clinical properties. In: European Journal of Nutrition. 2001 ; Vol. 40, No. 4. pp. 135-146.
@article{213718a278f64df28fe6563a41193b05,
title = "Isoflavones, substances with multi-biological and clinical properties",
abstract = "Isoflavones, rich in soybean, are currently receiving much attention because of their potential role in preventing and treating cancer and other human chronic diseases. The present review provides an overview of the recent results in this research field. Data from epidemiological reports and laboratories have shown that isoflavones have multi-biological and pharmacological effects in animals and humans. These include estrogenic and antiestrogenic effects, cell signalling conduction, as well as cell growth and death. Based on these properties, soy protein and isoflavones have been associated with reduced incidences of breast and prostate cancers, cardiovascular diseases or osteoporosis, and exhibit some other favorable effects. The mechanism through which isoflavones may exert the above-mentioned functions are not only based on the estrogenic properties of isoflavones, but also on their role as protein tyrosine kinase inhibitors, as regulators of gene transcription, modulators of transcription factors, antioxidants, as well as by altering some enzyme activities. However, to draw a clear conclusion regarding the clinical use of isoflavones further investigation would be required, although only a few effects of short- or longterm use of soy proteins are known in humans.",
keywords = "Cancer, Cholesterol, Estrogen receptor, Isoflavones, Soy protein",
author = "Mingqiang Ren and Gerda Kuhn and Jochen Wegner and Jie Chen",
year = "2001",
month = "1",
day = "1",
doi = "10.1007/PL00007388",
language = "English (US)",
volume = "40",
pages = "135--146",
journal = "European Journal of Nutrition",
issn = "1436-6207",
publisher = "D. Steinkopff-Verlag",
number = "4",

}

TY - JOUR

T1 - Isoflavones, substances with multi-biological and clinical properties

AU - Ren, Mingqiang

AU - Kuhn, Gerda

AU - Wegner, Jochen

AU - Chen, Jie

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Isoflavones, rich in soybean, are currently receiving much attention because of their potential role in preventing and treating cancer and other human chronic diseases. The present review provides an overview of the recent results in this research field. Data from epidemiological reports and laboratories have shown that isoflavones have multi-biological and pharmacological effects in animals and humans. These include estrogenic and antiestrogenic effects, cell signalling conduction, as well as cell growth and death. Based on these properties, soy protein and isoflavones have been associated with reduced incidences of breast and prostate cancers, cardiovascular diseases or osteoporosis, and exhibit some other favorable effects. The mechanism through which isoflavones may exert the above-mentioned functions are not only based on the estrogenic properties of isoflavones, but also on their role as protein tyrosine kinase inhibitors, as regulators of gene transcription, modulators of transcription factors, antioxidants, as well as by altering some enzyme activities. However, to draw a clear conclusion regarding the clinical use of isoflavones further investigation would be required, although only a few effects of short- or longterm use of soy proteins are known in humans.

AB - Isoflavones, rich in soybean, are currently receiving much attention because of their potential role in preventing and treating cancer and other human chronic diseases. The present review provides an overview of the recent results in this research field. Data from epidemiological reports and laboratories have shown that isoflavones have multi-biological and pharmacological effects in animals and humans. These include estrogenic and antiestrogenic effects, cell signalling conduction, as well as cell growth and death. Based on these properties, soy protein and isoflavones have been associated with reduced incidences of breast and prostate cancers, cardiovascular diseases or osteoporosis, and exhibit some other favorable effects. The mechanism through which isoflavones may exert the above-mentioned functions are not only based on the estrogenic properties of isoflavones, but also on their role as protein tyrosine kinase inhibitors, as regulators of gene transcription, modulators of transcription factors, antioxidants, as well as by altering some enzyme activities. However, to draw a clear conclusion regarding the clinical use of isoflavones further investigation would be required, although only a few effects of short- or longterm use of soy proteins are known in humans.

KW - Cancer

KW - Cholesterol

KW - Estrogen receptor

KW - Isoflavones

KW - Soy protein

UR - http://www.scopus.com/inward/record.url?scp=0035214590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035214590&partnerID=8YFLogxK

U2 - 10.1007/PL00007388

DO - 10.1007/PL00007388

M3 - Review article

C2 - 11905954

AN - SCOPUS:0035214590

VL - 40

SP - 135

EP - 146

JO - European Journal of Nutrition

JF - European Journal of Nutrition

SN - 1436-6207

IS - 4

ER -